We are live on
!
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $7.45M invested in Tonix Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more capital invested
Capital invested by funds: $6.07M → $7.45M (+$1.38M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$225K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$119K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$93K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$93K |
| 5 |
FMA
FNY Managed Accounts
New York
|
-$88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| – | -$22K | – | – |
|
|
LCM
27
Landscape Capital Management
Englewood,
New Jersey
| – | -$47K | – | – |
|
|
28
Renaissance Technologies
New York
| – | -$225K | – | – |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| – | -$11K | – | – |
|